Home » Archive by Tags

Articles tagged with: astrazeneca

AstraZeneca and Bristol-Myers report mixed data (BMY, AZN)
10/22/2009 – 12:15 pm PDT | No Comment

It was just three weeks ago when AstraZeneca and Bristol-Myers Squibb came up with an announcement that their new diabetes drug named Dapagliflozin has come up with positive results in the late-stage trial that combined …

AstraZeneca’s Crestor Approved (NYSE:AZN)
10/19/2009 – 7:00 am PDT | No Comment

It was a good closing day for AstraZeneca as they announced that the Food and Drug Administration has approved Crestor (rosuvastatin calcium) for use in pediatric patients suffering from heterozygous familial hypercholesterolemia (HeFH).

Dapagliflozin meets endpoints (NYSE:BMY)
10/05/2009 – 7:00 am PDT | No Comment

It was announced today that Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca’s diabetes drug dapagliflozin has successfully met the endpoints in the first phase III study. The companies together stated that their diabetes drug was able to …